The PiezoWave2 is a focused shockwave device used by therapists and doctors for the treatment of pain and damaged soft tissue. By the use of acoustic waves to target tissue at varying depths to compress and manipulate tissue – resulting in a focused and precise deep tissue massage. Unlike radial shockwave devices (which actually exert more of a pressure wave rather than shockwave), The focused therapy source allows you to pin point damaged tissue, target this region and treat effectively with no impact on healthy tissue. PiezoWave2 is the only focused system to offer a volume ESWT via a linear therapy source. The probe exerts a beam of 4.6 cm, allowing a painless treatment modality that covers a larger anatomical area in a shorter period of time. A guaranteed therapy source of up to 5 million shocks is provided, therefore the maintenance and ongoing costs are far lower than other devices.
Why focused shockwave?
- Quicker detection of restrictions in soft tissue
- Quicker and easier to break up tissue densities
- Helps reduce and heal scar tissue
- Perfect for acute and chronic conditions
- Decrease fatigue and slippage for the practitioner
- Guaranteed durability, of at least 5 million pulses
- Low noise level
- Convenient wheeled stand – easy movement of device, and appropriately designed extras for the different applications
- Precise and adjustable penetration depths
- Freely adjusted intensity levels with no impact on focal size
- Only shockwave to use direct focusing that does not require an additional reflector (no energy loss)
Conditions treatable with Focused Shockwave
A sound approach to treating acute and chronic musculoskeletal pain. Focused shockwave is widely used in the treatment of acute and chronic pain in muscles, tendons and joints. Focused shockwave describes the use of acoustic waves to target tissue at varying depths to compress and manipulate tissue resulting in a focused and precise deep tissue massage. The results of the mechanical stimulus delivered by focused shockwave can lead to increased circulation and pain relief – key components in the healing process. Focused shockwave is widely used in the musculosceletal system such as myofascial dysfunction and pain associated with triggerpoints.
- Soft tissue strains
- Myofascial dysfunction
- Trigger points
- Repetitive stress injuries
- Dysfunction in transitional regions between tendons and muscles
- Urology (erectile dysfunction)
- Cosmetics – cellulite, stretch marks and wrinkles
Focused and linear therapy- for pin pointed and macro treatments
The piezo-electric principle offers an extensive range of configurations. The only one of its kind in the world, the PiezoWave2 allows users to choose between a classic focused therapy source and a linear focused soundwave.
Why PiezoWave2 and Focused Shockwave are Unique
Other companies providing compression devices to treat musculoskeletal conditions do not utilise sound waves to create the compression. These devices rely on a percussive application to the outer layer of soft tissue with the hope that the resulting pressure will translate through the tissue to the targeted injury. The deeper the targeted structure the higher the impact required to the outer soft tissue layer with diminishing clinical results due to pressure absorption and increased patient discomfort at the point of contact.
PiezoWave2 sends an array of sound waves effortlessly and without sensation through soft tissue to the desired, controlled depth and at that point the sound focuses to create the compression. This results in a more controlled and effective delivery of energy along with greater patient compliance to the therapy.
The two methods of delivery could not be more different and according to clinicians who have used both devices so are the clinical outcomes.
PiezoWave2 and Focused Shockwave – Benefiting you and your patients
Improving patient outcomes improves the growth of your patient base and your reputation as an informed provider of effective therapies. According to PiezoWave2 clinicians adoption of focused shockwave has grown their patient base on an average of 25%.